Clinical factors asssociated with treatment outcomes following whole-brain irradiation in patients with prostate cancer

Liesa Dziggel, Steven E. Schild, Theo Veninga, Amira Bajrovic, Dirk Rades

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background/Aim: Patients with prostate cancer represent a small minority of cancer patients presenting with metastases to the brain. This study investigated the role of whole-brain irradiation (WBI) in this rare group. Patients and Methods: Eighteen such patients were included. Clinical factors including fractionation program of WBI, age at WBI, Karnofsky performance score (KPS), number of metastases to the brain, involvement of extracerebral metastatic sites, time from prostate cancer diagnosis to WBI and recursivepartitioning-analysis (RPA) class were investigated regarding local (intracerebral) control and survival. Results: On multivariate evaluation, longer time from prostate cancer diagnosis to WBI showed a trend towards improved local control (hazard ratio 2.77, p=0.098). Better KPS (hazard ratio 5.64, p=0.021) and longer time from prostate cancer diagnosis to WBI (hazard ratio 5.64, p=0.013) were significantly associated with better survival. Conclusion: Two independent predictors of survival were identified and should be considered when designing for personalized treatment regimens and clinical trials.

Original languageEnglish (US)
Pages (from-to)35-38
Number of pages4
JournalIn Vivo
Volume31
Issue number1
DOIs
StatePublished - 2017

Fingerprint

Brain
Prostatic Neoplasms
Irradiation
Hazards
Survival
Neoplasm Metastasis
Safety Management
Fractionation
Clinical Trials
Neoplasms

Keywords

  • Local control
  • Metastases to the brain
  • Prostate cancer
  • Survival.
  • WBI

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology

Cite this

Clinical factors asssociated with treatment outcomes following whole-brain irradiation in patients with prostate cancer. / Dziggel, Liesa; Schild, Steven E.; Veninga, Theo; Bajrovic, Amira; Rades, Dirk.

In: In Vivo, Vol. 31, No. 1, 2017, p. 35-38.

Research output: Contribution to journalArticle

Dziggel, Liesa ; Schild, Steven E. ; Veninga, Theo ; Bajrovic, Amira ; Rades, Dirk. / Clinical factors asssociated with treatment outcomes following whole-brain irradiation in patients with prostate cancer. In: In Vivo. 2017 ; Vol. 31, No. 1. pp. 35-38.
@article{72132bede8c34f6f9eb584d1f6506630,
title = "Clinical factors asssociated with treatment outcomes following whole-brain irradiation in patients with prostate cancer",
abstract = "Background/Aim: Patients with prostate cancer represent a small minority of cancer patients presenting with metastases to the brain. This study investigated the role of whole-brain irradiation (WBI) in this rare group. Patients and Methods: Eighteen such patients were included. Clinical factors including fractionation program of WBI, age at WBI, Karnofsky performance score (KPS), number of metastases to the brain, involvement of extracerebral metastatic sites, time from prostate cancer diagnosis to WBI and recursivepartitioning-analysis (RPA) class were investigated regarding local (intracerebral) control and survival. Results: On multivariate evaluation, longer time from prostate cancer diagnosis to WBI showed a trend towards improved local control (hazard ratio 2.77, p=0.098). Better KPS (hazard ratio 5.64, p=0.021) and longer time from prostate cancer diagnosis to WBI (hazard ratio 5.64, p=0.013) were significantly associated with better survival. Conclusion: Two independent predictors of survival were identified and should be considered when designing for personalized treatment regimens and clinical trials.",
keywords = "Local control, Metastases to the brain, Prostate cancer, Survival., WBI",
author = "Liesa Dziggel and Schild, {Steven E.} and Theo Veninga and Amira Bajrovic and Dirk Rades",
year = "2017",
doi = "10.21873/invivo.11021",
language = "English (US)",
volume = "31",
pages = "35--38",
journal = "In Vivo",
issn = "0258-851X",
publisher = "International Institute of Anticancer Research",
number = "1",

}

TY - JOUR

T1 - Clinical factors asssociated with treatment outcomes following whole-brain irradiation in patients with prostate cancer

AU - Dziggel, Liesa

AU - Schild, Steven E.

AU - Veninga, Theo

AU - Bajrovic, Amira

AU - Rades, Dirk

PY - 2017

Y1 - 2017

N2 - Background/Aim: Patients with prostate cancer represent a small minority of cancer patients presenting with metastases to the brain. This study investigated the role of whole-brain irradiation (WBI) in this rare group. Patients and Methods: Eighteen such patients were included. Clinical factors including fractionation program of WBI, age at WBI, Karnofsky performance score (KPS), number of metastases to the brain, involvement of extracerebral metastatic sites, time from prostate cancer diagnosis to WBI and recursivepartitioning-analysis (RPA) class were investigated regarding local (intracerebral) control and survival. Results: On multivariate evaluation, longer time from prostate cancer diagnosis to WBI showed a trend towards improved local control (hazard ratio 2.77, p=0.098). Better KPS (hazard ratio 5.64, p=0.021) and longer time from prostate cancer diagnosis to WBI (hazard ratio 5.64, p=0.013) were significantly associated with better survival. Conclusion: Two independent predictors of survival were identified and should be considered when designing for personalized treatment regimens and clinical trials.

AB - Background/Aim: Patients with prostate cancer represent a small minority of cancer patients presenting with metastases to the brain. This study investigated the role of whole-brain irradiation (WBI) in this rare group. Patients and Methods: Eighteen such patients were included. Clinical factors including fractionation program of WBI, age at WBI, Karnofsky performance score (KPS), number of metastases to the brain, involvement of extracerebral metastatic sites, time from prostate cancer diagnosis to WBI and recursivepartitioning-analysis (RPA) class were investigated regarding local (intracerebral) control and survival. Results: On multivariate evaluation, longer time from prostate cancer diagnosis to WBI showed a trend towards improved local control (hazard ratio 2.77, p=0.098). Better KPS (hazard ratio 5.64, p=0.021) and longer time from prostate cancer diagnosis to WBI (hazard ratio 5.64, p=0.013) were significantly associated with better survival. Conclusion: Two independent predictors of survival were identified and should be considered when designing for personalized treatment regimens and clinical trials.

KW - Local control

KW - Metastases to the brain

KW - Prostate cancer

KW - Survival.

KW - WBI

UR - http://www.scopus.com/inward/record.url?scp=85015813697&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015813697&partnerID=8YFLogxK

U2 - 10.21873/invivo.11021

DO - 10.21873/invivo.11021

M3 - Article

C2 - 28064217

AN - SCOPUS:85015813697

VL - 31

SP - 35

EP - 38

JO - In Vivo

JF - In Vivo

SN - 0258-851X

IS - 1

ER -